ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
0,00%
Bitcoin
66.894,05
-0,28%
Brent Oil
83,76
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Otonomy Inc (OTIC)

  7. Otonomy Inc (OTIC) Notícias

OTIC

Otonomy (OTIC)

Otonomy Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OTIC
DataHoraFonteTítuloCódigoCompanhia
04/04/202316:41Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:OTICOtonomy Inc
03/04/202307:19Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OTICOtonomy Inc
30/03/202317:32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OTICOtonomy Inc
30/03/202317:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OTICOtonomy Inc
30/03/202317:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTICOtonomy Inc
24/02/202318:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OTICOtonomy Inc
14/02/202318:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTICOtonomy Inc
13/02/202318:57Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OTICOtonomy Inc
30/01/202308:38Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OTICOtonomy Inc
30/12/202218:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTICOtonomy Inc
29/12/202211:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OTICOtonomy Inc
27/12/202219:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OTICOtonomy Inc
22/12/202209:53GlobeNewswire Inc.Otonomy Announces Change in Stock Exchange ListingNASDAQ:OTICOtonomy Inc
19/12/202219:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OTICOtonomy Inc
19/12/202218:53GlobeNewswire Inc.Otonomy Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
10/11/202218:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OTICOtonomy Inc
10/11/202218:05GlobeNewswire Inc.Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
13/10/202208:30GlobeNewswire Inc.Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing LossNASDAQ:OTICOtonomy Inc
02/08/202217:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OTICOtonomy Inc
02/08/202207:16TipRanksAnalyst Explains Why They Downgraded Their Rating on Otonomy (OTIC)NASDAQ:OTICOtonomy Inc
01/08/202208:30GlobeNewswire Inc.Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with TinnitusNASDAQ:OTICOtonomy Inc
25/07/202217:05GlobeNewswire Inc.Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
18/07/202208:30GlobeNewswire Inc.Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate UpdateNASDAQ:OTICOtonomy Inc
18/05/202208:30GlobeNewswire Inc.Otonomy to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:OTICOtonomy Inc
12/05/202208:30GlobeNewswire Inc.Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual MeetingNASDAQ:OTICOtonomy Inc
09/05/202217:04GlobeNewswire Inc.Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:OTICOtonomy Inc
02/05/202208:30GlobeNewswire Inc.Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate UpdateNASDAQ:OTICOtonomy Inc
25/04/202207:15TipRanksAnalysts Offer Insights on Healthcare Companies: Amryt Pharma (AMYT) and Otonomy (OTIC)NASDAQ:OTICOtonomy Inc
20/04/202208:30GlobeNewswire Inc.Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing LossNASDAQ:OTICOtonomy Inc
15/03/202208:30GlobeNewswire Inc.Otonomy to Host Virtual Investor R&D Event on March 22, 2022NASDAQ:OTICOtonomy Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:OTIC

Seu Histórico Recente

LBNK
JBCUSDT
JBC
BOV
B1AM34M
Brookfield
NYSE
BBT-E
BB and T
AMEX
JQUA
Jpmorgan US Quality Fact...
TSXV
MIP
LATK
CCOINETH
CREDITCOIN
COIN
PIRLUSD
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados